ArticleCureus2025
Primary Omental Leiomyosarcoma With Pulmonary Metastases: A Case Report of Surgical Management and Chemotherapy Response.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary omental leiomyosarcoma is an extraordinarily rare tumor, with only a limited number of cases reported in the medical literature. Early surgical intervention appears to be a key determinant in the successful treatment of this malignancy, although more cases are needed to establish a standardized approach for optimal management. Leiomyosarcomas originating from the omentum present unique diagnostic challenges due to their rarity and often nonspecific clinical and radiologic findings. The complexities of diagnosing and managing this condition are compounded in rural areas where access to advanced diagnostic tools and specialists is limited. Leiomyosarcomas appear on abdominal computerized tomography (CT) as heterogeneous solid masses with cystic areas that enhance with contrast. While imaging can suggest the diagnosis, histopathology is required for confirmation. These tumors are highly aggressive, and complete surgical resection is the only definitive treatment, with resectability depending on peritoneal implants or metastasis. Other treatments, such as chemotherapy, radiation, and embolization, have variable success. Liver metastasis is the most common and a poor prognostic factor. Despite alternative therapies, surgery remains the best option for long-term survival. This case not only highlights the rarity and diagnostic challenges of omental leiomyosarcoma but also underscores the importance of timely referral to specialized centers. It further emphasizes the need for comprehensive diagnostic evaluations and personalized treatment plans tailored to the unique characteristics of each patient. Addressing these challenges through early intervention and targeted therapies is crucial to improving outcomes for patients with rare malignancies like omental leiomyosarcoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.